These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The current state of multiple sclerosis genetic research. Rubio JP; Speed TP; Bahlo M; Kilpatrick TJ; Foote SJ Ann Acad Med Singap; 2000 May; 29(3):322-30. PubMed ID: 10976385 [TBL] [Abstract][Full Text] [Related]
28. Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways. Liu G; Zhang F; Jiang Y; Hu Y; Gong Z; Liu S; Chen X; Jiang Q; Hao J Mult Scler; 2017 Feb; 23(2):205-212. PubMed ID: 27207450 [TBL] [Abstract][Full Text] [Related]
29. Genome-wide association studies in multiple sclerosis: lessons and future prospects. Kemppinen A; Sawcer S; Compston A Brief Funct Genomics; 2011 Mar; 10(2):61-70. PubMed ID: 21310812 [TBL] [Abstract][Full Text] [Related]
30. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493 [TBL] [Abstract][Full Text] [Related]
31. The genetic basis of multiple sclerosis: a model for MS susceptibility. Goodin DS BMC Neurol; 2010 Oct; 10():101. PubMed ID: 21029420 [TBL] [Abstract][Full Text] [Related]
32. Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans. Brambilla P; Esposito F; Lindstrom E; Sorosina M; Giacalone G; Clarelli F; Rodegher M; Colombo B; Moiola L; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; Celius EG; Galimberti D; Sørensen PS; Martinelli V; Oturai AB; Harbo HF; Hillert J; Comi G; Martinelli-Boneschi F Neurosci Lett; 2012 Nov; 530(2):155-60. PubMed ID: 23069673 [TBL] [Abstract][Full Text] [Related]
34. Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. Lin R; Charlesworth J; Stankovich J; Perreau VM; Brown MA; ; Taylor BV PLoS One; 2013; 8(3):e56379. PubMed ID: 23472070 [TBL] [Abstract][Full Text] [Related]
35. The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. Baranzini SE; Oksenberg JR Trends Genet; 2017 Dec; 33(12):960-970. PubMed ID: 28987266 [TBL] [Abstract][Full Text] [Related]
36. The immunogenetics of multiple sclerosis: A comprehensive review. Hollenbach JA; Oksenberg JR J Autoimmun; 2015 Nov; 64():13-25. PubMed ID: 26142251 [TBL] [Abstract][Full Text] [Related]
38. A genome-wide association study in progressive multiple sclerosis. Martinelli-Boneschi F; Esposito F; Brambilla P; Lindström E; Lavorgna G; Stankovich J; Rodegher M; Capra R; Ghezzi A; Coniglio G; Colombo B; Sorosina M; Martinelli V; Booth D; Oturai AB; Stewart G; Harbo HF; Kilpatrick TJ; Hillert J; Rubio JP; Abderrahim H; Wojcik J; Comi G Mult Scler; 2012 Oct; 18(10):1384-94. PubMed ID: 22457343 [TBL] [Abstract][Full Text] [Related]
39. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. Ramagopalan SV; McMahon R; Dyment DA; Sadovnick AD; Ebers GC; Wittkowski KM BMC Med Genet; 2009 Feb; 10():10. PubMed ID: 19193207 [TBL] [Abstract][Full Text] [Related]
40. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study. Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]